Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
3.915
+0.095 (2.49%)
Nov 4, 2024, 4:00 PM EST - Market closed
Arcadia Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -6.78 | -13.98 | -15.38 | -14.66 | -4.66 | -28.81 | Upgrade
|
| Depreciation & Amortization | 0.93 | 0.98 | 1.36 | 2.32 | 1.71 | 0.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.1 | -0.04 | -0.31 | 0.25 | -0.01 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.15 | 0.11 | 0.93 | 6.48 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -1.14 | -10.22 | -9.51 | -0.18 | Upgrade
|
| Stock-Based Compensation | 0.55 | 0.72 | 1.11 | 1.54 | 2.04 | 2.29 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.02 | 0.02 | 0.06 | 0.08 | - | - | Upgrade
|
| Other Operating Activities | -1.13 | 0.4 | -0.73 | -7.39 | -7.42 | 9.19 | Upgrade
|
| Change in Accounts Receivable | -0.24 | 0.18 | 0.59 | -0.04 | -1.12 | -0.43 | Upgrade
|
| Change in Inventory | -0.66 | -2.42 | 1.12 | -2.38 | -9.75 | -1.54 | Upgrade
|
| Change in Accounts Payable | -0.99 | -0.52 | -0.76 | -0.37 | -0.58 | 2.1 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.01 | -0.03 | -0.05 | Upgrade
|
| Change in Other Net Operating Assets | -0.44 | -0.75 | -0.84 | -1.46 | -0.89 | -0.67 | Upgrade
|
| Operating Cash Flow | -12.7 | -15.29 | -13.98 | -25.87 | -30.22 | -17.2 | Upgrade
|
| Capital Expenditures | -0.02 | -0.01 | -0.07 | -1.01 | -2.34 | -1.48 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | 0.12 | 0.92 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -4.25 | -0.5 | - | Upgrade
|
| Investment in Securities | 2.48 | -4.45 | 0.57 | 21.85 | 20.11 | -6.91 | Upgrade
|
| Investing Cash Flow | 4.7 | -4.34 | 1.42 | 16.61 | 17.28 | -8.37 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3.11 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 3.11 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -2.15 | -0.03 | -0.01 | Upgrade
|
| Total Debt Repaid | - | - | - | -2.15 | -0.03 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -2.15 | 3.07 | -0.01 | Upgrade
|
| Issuance of Common Stock | 0.01 | 6.01 | 5.01 | 25.21 | 17.42 | 22.79 | Upgrade
|
| Other Financing Activities | - | -0.5 | -0.49 | -1.16 | 0.06 | -0.8 | Upgrade
|
| Financing Cash Flow | 0.01 | 5.51 | 4.52 | 21.9 | 20.56 | 21.99 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | -7.98 | -14.13 | -8.04 | 12.64 | 7.63 | -3.58 | Upgrade
|
| Free Cash Flow | -12.71 | -15.3 | -14.05 | -26.88 | -32.55 | -18.68 | Upgrade
|
| Free Cash Flow Margin | -242.41% | -287.04% | -189.39% | -396.39% | -405.19% | -1597.52% | Upgrade
|
| Free Cash Flow Per Share | -9.33 | -12.37 | -23.44 | -50.52 | -130.75 | -117.40 | Upgrade
|
| Cash Interest Paid | - | - | 0 | 0.03 | 0.01 | 0 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -7.43 | -5.73 | -5.25 | -13.52 | -12.91 | -10.88 | Upgrade
|
| Unlevered Free Cash Flow | -7.43 | -5.73 | -5.25 | -13.5 | -12.88 | -10.87 | Upgrade
|
| Change in Net Working Capital | 0.46 | -0.96 | -1.18 | 1.16 | 3.54 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.